Protein Degraded. Disease Targeted. Lives Transformed.
C4 Therapeutics (c4therapeutics.com) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 33rd percentile of 14026 Healthcare brands.
C4 Therapeutics is a biopharmaceutical company founded in 2015 and headquartered in Watertown, United States. It focuses on developing targeted protein degradation (TPD) therapies aimed at treating serious diseases, including multiple myeloma and other cancers. The company works to address disease targets previously considered undruggable, aiming to provide new treatment options for patients, healthcare providers, and biopharmaceutical partners within the medical and scientific community.
| Brand Name | C4 Therapeutics |
|---|---|
| Domain | c4therapeutics.com |
| Industry | Healthcare |
| Founded | 2015 |
| Headquarters | Watertown, United States |
| Main Competitors | Arvinas (80/100), Kymera Therapeutics (76/100), Nurix Therapeutics (73/100), Foghorn Therapeutics (55/100), Monte Rosa Therapeutics (76/100), Vividion Therapeutics (75/100) |
Moz Domain Authority 40/100 vs category average 41 / leader 97 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To develop targeted protein degradation therapies that transform the lives of patients with serious diseases." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
C4 Therapeutics's main competitors in Healthcare: Arvinas (80/100), Kymera Therapeutics (76/100), Nurix Therapeutics (73/100), Foghorn Therapeutics (55/100), Monte Rosa Therapeutics (76/100).
Sources: Brand Analyzer scan
C4 Therapeutics has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 52, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: C4 Therapeutics official site
C4 Therapeutics was founded in 2015. C4 Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
C4 Therapeutics scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: C4 Therapeutics official site
C4 Therapeutics is a biopharmaceutical company, founded in 2015 and based in Watertown, United States, that specializes in targeted protein degradation (TPD) science to develop novel medicines for serious diseases.
Sources: C4 Therapeutics official site
C4 Therapeutics develops targeted protein degradation therapies designed to address disease targets that are difficult or impossible to treat with conventional drugs. Its work focuses on creating novel medicines for cancer and other serious conditions, including multiple myeloma, with the goal of providing new treatment options for patients.
Sources: C4 Therapeutics official site
C4 Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: C4 Therapeutics official site
C4 Therapeutics develops targeted protein degradation (TPD) therapies rather than traditional consumer products. These are novel medicines designed to treat serious diseases, including certain cancers such as multiple myeloma, by targeting previously undruggable disease-related proteins.
Sources: C4 Therapeutics official site
C4 Therapeutics is known for pioneering targeted protein degradation (TPD) science, a therapeutic approach used to develop treatments for previously undruggable disease targets, particularly in the context of cancers such as multiple myeloma.
Sources: C4 Therapeutics official site
C4 Therapeutics' work is intended for patients with serious diseases such as multiple myeloma, and it engages with healthcare providers, biopharmaceutical partners, and the broader medical and scientific community in the development and application of its therapies.
Sources: C4 Therapeutics official site
C4 Therapeutics scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
C4 Therapeutics has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 40/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to C4 Therapeutics: BuzzRx (73/100), WOW Skin Science (73/100), CAAHEP (73/100), CAHME (Commission on Accreditation of Healthcare Management Education) (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.